Kedudukan dalam Saham
#42305
Regnum Corp. is dedicated to advancing and marketing therapeutic agents... Regnum Corp. is dedicated to advancing and marketing therapeutic agents designed to combat both rare and infectious diseases. Its flagship product is Leronlimab (PRO 140), a monoclonal antibody functioning as a C-C chemokine receptor type 5 (CCR5) antagonist. This drug is specifically formulated to inhibit the human immunodeficiency virus (HIV) from gaining entry into human cells. Headquartered in New York, New York, Regnum Corp. operates as a subsidiary of Phoenixus AG.
Harga Saham
$0.0001
Disegerakkan terakhir: 2026-08-11
Perubahan (1 tahun)
0.00%
Perdagangan Regnum Corp. (RGMP)
Harga RGMP dengan permodalan pasaran b
Modal pasaran bagi Regnum Corp.(RGMP)
Modal Pasaran: $2.30K
Sehingga August 2026, Regnum Corp. mempunyai modal pasaran sebanyak $2.30K. Ini menjadikan Regnum Corp. syarikat ke-42305th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Regnum Corp. dari 2019 hingga 2026
RGMP berbanding dengan 5 teratas yang paling popular stocks
| Harga RGMP |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.383T
|
+234,569,039,551.42%
|
|
|
|
|
$4.423T
|
+192,740,357,361.35%
|
|
|
|
|
$4.160T
|
+181,279,712,278.30%
|
|
|
|
|
$3.663T
|
+159,621,822,862.96%
|
|
|
|
|
$2.891T
|
+125,979,468,109.15%
|
